2401 Results

People

  1. Offit
    Offit
  2. Ladanyi
    Ladanyi
  3. Robson
    Robson
  4. Levine
    Levine
  5. Abdel-Wahab
    Abdel-Wahab
  6. Riely
    Riely
  7. Solit
    Solit
  8. Antonescu
    Antonescu
  9. Kris
    Kris
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (1068)
  2. GSK Faculty (1015)
  3. Solid Tumor Oncology Division (708)
  4. Department of Pathology and Laboratory Medicine (533)
  5. Surgery (466)
  6. Sloan Kettering Institute Faculty (463)
  7. Human Oncology and Pathogenesis Program (372)
  8. Hematologic Malignancies, Division of (360)
  9. Tow Center for Developmental Oncology (TCDO) (359)
  10. Sloan Kettering Institute Postdocs (345)
  1. "gene mutation"
Formats
  1. Journal Article (2161)
  2. Review (112)
  3. Editorial (55)
  4. Research Letter (36)
  5. Conference Paper (11)
  6. Correspondence (10)
  7. Miscellaneous (7)
  8. Guidelines (6)
  9. Meeting Abstract (3)
Groups
  1. Department of Medicine (1068)
  2. GSK Faculty (1015)
  3. Solid Tumor Oncology Division (708)
  4. Department of Pathology and Laboratory Medicine (533)
  5. Surgery (466)
  6. Sloan Kettering Institute Faculty (463)

More Groups

People
  1. Kenneth Offit (139)
  2. Marc Ladanyi (112)
  3. Mark Robson (94)
  4. Ross Levine (85)
  5. Omar Abdel-Wahab (75)
  6. Gregory Riely (62)

More People

Years
  1. 2025 (70)
  2. 2024 (169)
  3. 2023 (103)
  4. 2022 (99)
  5. 2021 (59)
  6. 2020 (125)

More Years

Publications
  1. Clinical Cancer Research (97)
  2. Proceedings of the National Academy of Sciences of the United States of America (71)
  3. Journal of Clinical Oncology (62)
  4. Cancer Research (50)
  5. Nature (50)
  6. Blood (44)

More Publications

Publishers
  1. Nature Publishing Group (258)
  2. Elsevier Inc. (226)
  3. American Association for Cancer Research (190)
  4. Oxford University Press (124)
  5. Springer (117)
  6. Cell Press (114)

More Publishers

Results (2401)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: Recommendations from the International Association for the Study of Lung Cancer Pathology Committee
    Review

    Chou, T. Y.; Dacic, S.; Wistuba, I.; Beasley, M. B.; Berezowska, S.; Chang, Y. C.; Chung, J. H.; Connolly, C.; Han, Y.; Hirsch, F. R.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • A podcast discussion on the intracranial efficacy of antibody–Drug conjugates in patients with EGFR-mutated NSCLC with brain metastases
    Editorial

    Johnson, M. L.; Lin, J. J.; Boire, A.; Khandekar, M. J.; Yu, H. A.
    Oncology and Therapy (2025)

    Fulltext@MSK | Save
  • Cerebellar output neurons can impair non-motor behaviors by altering development of extracerebellar connectivity
    Journal Article

    Lee, A. S.; Arefin, T. M.; Gubanova, A.; Stephen, D. N.; Liu, Y.; Lao, Z.; Krishnamurthy, A.; De Marco García, N. V.; Heck, D. H.; Zhang, J.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases
    Journal Article

    Sotirchos, V. S.; Silk, M. T.; Camacho, J. C.; Schatoff, E. M.; Kunin, H. S.; Alexander, E. S.; Zhao, K.; Connell, L. C.; Sofocleous, C. T.; Kemeny, N. E.
    Journal of Gastrointestinal Oncology (2025)

    Fulltext@MSK | Save
  • REZILIENT3: Randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLC
    Journal Article

    Heymach, J. V.; Yu, H. A.; Besse, B.; Cheng, Y.; Tan, D. S. W.; Wei, L.; Wacheck, V.; Nishio, M.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapy
    Journal Article

    Jansen, P.; Galetzka, W.; Thielmann, C. M.; Murali, R.; Zaremba, A.; Standl, F.; Lodde, G.; Möller, I.; Sucker, A.; Paschen, A.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumors
    Journal Article

    Schram, A. M.; Boni, V.; Adjei, A. A.; Olszanski, A. J.; Vieito, M.; Francis, J. H.; Kurman, M.; Ahsan, J. M.; Tomkinson, B.; Garralda, E.
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Immune checkpoint blockade response in mucinous tubular and spindle cell carcinoma
    Journal Article

    Makker, S.; Shah, N. J.; Carlo, M. I.; Kuo, F.; Hakimi, A. A.; Chen, Y. B.; Iyer, G.; Kotecha, R. R.
    Current Oncology (2025)

    Fulltext@MSK | Save
  • Future initiatives and approaches to reducing the impact of lung cancer
    Editorial

    Kim, D.
    Cancer Cytopathology (2025)

    Fulltext@MSK | Save